How to Sell a Care Home Business UK: 2026

The UK care home sector has become one of the most active M&A markets in the country. Knight Frank reported that UK healthcare property transactions hit a record GBP 12 billion in 2025 - more than three times the five-year annual average of GBP 2.4 billion. That momentum has not slowed. If you own a care home and are considering a sale, this is the most favourable seller's market in at least a decade.

The numbers tell the story. Welltower, the US healthcare REIT, spent GBP 6.4 billion in a single quarter to acquire Barchester Healthcare (GBP 5.2 billion for 240+ care homes and 14,440 beds) and HC-One (GBP 1.2 billion for nearly 300 homes and 15,000 residents). Foundation Partners bought Hartford Care for GBP 100 million. CareTrust entered the UK market with a GBP 448 million acquisition of Care REIT. These are not isolated events. They represent a structural shift in how global capital views UK adult social care.

This guide covers what your care home business is worth in 2026, who the buyers are, how to prepare for a sale, and how to manage the CQC regulatory process that makes care home transactions unique.

What Is Your Care Home Worth in 2026?

Valuations depend on several factors, but the primary driver remains EBITDA (or EBITDARM for investors focused on the real estate component). Knight Frank's 2025 UK Care Homes Trading Performance Review showed average EBITDARM margins growing to 30.1%, up four percentage points from the prior year. Average weekly fees reached GBP 1,298, up 9.8% year-on-year.

The multiple a buyer will pay depends on size, CQC rating, funding mix, and property tenure.

2026 UK Care Home EBITDA Multiples

For context, a well-run 40-bed residential care home with GBP 300,000 EBITDA, a Good CQC rating, and freehold property might trade at 7x-8x, producing a sale value of GBP 2.1 million to GBP 2.4 million. A group of five homes generating GBP 1.5 million combined EBITDA with consistent Good ratings and a mix of nursing and residential beds could command 8x-9x, or GBP 12 million to GBP 13.5 million.

Property tenure matters significantly. Freehold care homes attract materially higher multiples because the buyer acquires both the business and the underlying real estate. Leasehold operations carry lease renewal risk and rent escalation, which discounts the multiple by up to 2x according to DNS Associates' 2025 sector analysis. Homes rated Requires Improvement typically trade at 5x-6x EBITDA or lower, regardless of other factors.

Who Is Buying UK Care Homes in 2026?

The buyer pool has expanded dramatically. The days when care home sales meant finding a local operator willing to pay GBP 50,000 to GBP 80,000 per bed are fading. Today's market includes international REITs, sovereign wealth funds, PE firms, and large corporate groups - all competing for quality assets.

The Major Corporate and REIT Buyers

Welltower is now the dominant force in UK care homes. Following its GBP 5.2 billion Barchester acquisition and GBP 1.2 billion HC-One purchase, it controls a GBP 10 billion UK portfolio including Avery, Signature, Sunrise, and Care UK. Welltower's appetite for UK care homes shows no sign of slowing - the company described the UK as a key destination for international capital.

HC-One itself has been active as a consolidator, acquiring Ideal Carehomes (36 homes) from Warwick Capital Partners before its own sale to Welltower. Barchester Healthcare operates 240+ homes with 14,440 beds and 17,000 staff. Cygnet Health Care was the most active trade buyer in H1-H3 2025 according to MarktoMarket's UK Healthcare M&A report, alongside Potens, Amaya Care Homes, and Hatford.

CareTrust entered the UK market with its GBP 448 million acquisition of Care REIT, and Foundation Partners paid GBP 100 million for Hartford Care. US capital has accounted for a high proportion of UK transaction volumes, and this cross-border appetite is expected to continue into 2026 and beyond.

For owners of smaller care home businesses, DealFlowAgent's buy-side service can identify which of these groups and their regional acquisition teams are actively seeking assets in your geography. The same consolidation dynamics driving record veterinary practice acquisition activity are now firmly established in the care home sector, with PE firms and REITs competing for quality assets across UK healthcare.

What Buyers Look For

Every serious buyer runs the same core analysis:

• CQC rating: Good or Outstanding is non-negotiable for most institutional buyers. A Requires Improvement rating will either kill the deal or significantly discount the price.
• Occupancy rate: The national average is 85.8% as of February 2026 according to GOV.UK capacity tracker data. Homes operating above 90% signal strong local demand and good management.
• Funding mix: Self-funded (private pay) residents generate higher fees and margins than local authority-funded residents. A higher ratio of self-funded beds typically drives a premium multiple.
• Property condition and tenure: Freehold, purpose-built or well-maintained converted homes with modern facilities attract the strongest interest.
• Management independence: Buyers pay more when the home operates without daily involvement from the owner. A strong registered manager and stable staff team de-risk the transition.
• Nursing capability: Homes registered for both residential and nursing care access a wider pool of residents and command higher weekly fees.

Preparing Your Care Home for Sale

Preparation is the difference between an average exit and a premium one. Start at least 12 months before you plan to market the business.

1. Secure and Maintain Your CQC Rating

This is the single most important factor. If your home is rated Good, do everything to protect that rating. If it is Requires Improvement, address the shortfalls before going to market. The CQC has committed to completing 9,000 assessments by September 2026 under the new Single Assessment Framework, so the likelihood of an inspection before or during a sale process is high.

From 9 February 2026, the CQC introduced stricter registration requirements. Incomplete applications are now immediately rejected - no second chances. If your sale involves an asset transfer requiring buyer re-registration, both you and the buyer need to be prepared with detailed business plans, two-year financial forecasts, evidence of legal occupancy, service user guides, and staff training plans.

2. Strengthen Your Financial Performance

Buyers focus on EBITDA and EBITDARM margins. Knight Frank's 2025 data shows the sector average EBITDARM margin at 30.1%. If your home is below that, identify where costs can be reduced without compromising care quality. Common areas include:

• Agency staff reliance (this is a major red flag for buyers)
• Catering and housekeeping contracts (often renegotiable)
• Energy costs (particularly in older buildings)
• Insurance and maintenance contracts

Occupancy is the other critical lever. Every empty bed is lost revenue. If your home has admittable vacancies above the 10.8% national average, focus on marketing, hospital discharge relationships, and local authority referral pathways before listing the business.

3. Reduce Owner Dependency

If you are the registered manager, the nominated individual, or the person residents and families know by name, the business has a key-person risk. Buyers will discount for this. Ideally, you should have an experienced registered manager who has been in post for at least 12 months before the sale, with the home demonstrably operating without your daily involvement.

4. Clean Your Records

CQC notifications, complaints records, safeguarding logs, staff DBS checks, medication audit trails, fire risk assessments, maintenance records - all of these will be scrutinised during due diligence. Missing or disorganised records slow the process and create doubt in the buyer's mind about how well the home is managed.

5. Understand Your Property Position

If you own the freehold, get a current RICS valuation. If you operate under a lease, review the terms - particularly around change of control clauses, rent review mechanisms, and remaining lease length. A lease with fewer than 15 years remaining will concern most buyers.

The Care Home Sale Process

A typical UK care home sale takes 6-12 months from initial marketing to completion, according to Healthcare Property. The timeline is often longer than in other sectors because of the CQC regulatory requirements.

Stage 1: Valuation and Preparation (Month 1-2)

Your advisor produces a detailed valuation based on financial performance, property, CQC rating, local market conditions, and comparable transactions. This is also when you address any gaps identified in preparation.

Stage 2: Confidential Marketing (Month 2-4)

The business is presented to a targeted list of qualified buyers under NDA. For care homes, this typically includes regional operators, corporate groups, REITs, and PE-backed platforms. The information memorandum covers financial performance, CQC inspection history, resident profile, staffing structure, and property details.

Stage 3: Offers and Heads of Terms (Month 4-5)

Interested buyers submit indicative offers. You negotiate heads of terms with the preferred buyer, covering price, deal structure (share sale or asset sale), completion conditions, and any deferred or contingent consideration.

Stage 4: Due Diligence (Month 5-8)

The buyer's team examines financial records, CQC compliance history, employment contracts, property surveys, and operational data. This is where preparation pays off - well-organised records accelerate the process.

Stage 5: CQC Process (Concurrent with Due Diligence)

This is unique to regulated care businesses. As Stephens Scown's care business guide explains:

• Share sale: The buyer notifies CQC after completion. Typically faster, as the existing CQC registration remains with the company.
• Asset sale: The buyer must apply for new CQC registration before completion. This process takes approximately 16-20 weeks and requires a split exchange and completion structure.

Many sellers prefer share sales for this reason, but the choice depends on tax planning (including BADR relief implications), the buyer's existing corporate structure, and any liabilities sitting within the company.

Stage 6: Completion (Month 8-12)

Contracts exchange and complete. Staff transfer under TUPE regulations. The registered manager either continues in post or a new manager is installed (with CQC approval if required).

Tax Considerations for Care Home Sellers

The April 2026 BADR tax changes are directly relevant. The Capital Gains Tax rate under Business Asset Disposal Relief is increasing from 14% to 18%, with the lifetime allowance remaining at GBP 1 million. For a care home owner selling a business for GBP 3 million with GBP 1 million of qualifying gains, the difference between the old 10% rate and the new 18% rate is GBP 80,000 in additional tax on the first GBP 1 million alone. Our detailed guide on the BADR changes covers the anti-forestalling rules and how they affect deal timing.

Inheritance tax is also a factor for family-owned care homes. Business Property Relief currently allows trading businesses to pass free of IHT, but proposed changes to agricultural and business property reliefs could affect succession planning for care home owners who hold both the operating business and the freehold property.

Why 2026 Is a Strong Year to Sell

Several factors make the current market unusually favourable for care home sellers:

• Record investment volumes: Knight Frank's GBP 12 billion in 2025 healthcare transactions signals sustained institutional appetite.
• Ageing demographics: The UK needs 144,000 additional care beds over the next decade according to Savills projections.
• Rising fees: Average weekly fees up 9.8% to GBP 1,298, with EBITDARM margins at 30.1%.
• Cross-border capital: US, Middle Eastern, and Asian investors are actively targeting UK care assets for their countercyclical characteristics.
• Stable occupancy: National occupancy at 85.8% with improving trends, particularly in nursing beds.
• Regulatory clarity: The CQC's Single Assessment Framework is now established, giving buyers confidence in the regulatory environment.

The risk of waiting is that multiples compress if interest rates remain elevated, or if a new regulatory burden increases operating costs. Our earlier guide to selling a care home business covers the fundamentals, while this post reflects the transformed market conditions of 2026. Owners who have built strong, well-rated homes with good financial performance are in the best position they have been in for years.

Frequently Asked Questions

How much is a UK care home worth?

A single care home typically sells for 5x-8x EBITDA depending on size, CQC rating, and property tenure. Small chains (2-5 homes) command 7x-9x, while large platforms with 15+ homes can achieve 10x-14x or higher. Freehold homes attract materially higher multiples than leasehold operations.

How long does it take to sell a care home?

Most UK care home sales complete within 6-12 months. The timeline depends on deal structure - share sales are typically faster because they avoid the CQC re-registration process. Asset sales require the buyer to obtain new CQC registration, which takes approximately 16-20 weeks.

Do I need CQC approval to sell my care home?

If you sell via a share sale, you notify CQC after completion. If you sell the business as an asset sale, the buyer must apply for CQC registration before completion. Both the seller and buyer must submit applications, and the CQC links them. From February 2026, incomplete applications are immediately rejected.

What CQC rating do I need to sell?

Good or Outstanding is strongly preferred by most buyers. A Requires Improvement rating will significantly reduce your sale price - often to 5x-6x EBITDA or lower - and limit your buyer pool to turnaround specialists willing to invest in remediation.

Should I choose a share sale or asset sale?

Share sales are faster (no CQC re-registration) and may be simpler, but they transfer all company liabilities to the buyer, which can affect the price. Asset sales allow a clean transfer but require CQC re-registration (16-20 weeks) and a split exchange and completion. Tax implications under BADR also differ between the two structures.

What is the biggest factor in care home valuation?

For most buyers, the combination of CQC rating and EBITDA margin matters most. A Good-rated home with a 30%+ EBITDARM margin, occupancy above 88%, and a strong self-funded resident mix will command the highest multiples. Property tenure (freehold vs leasehold) is the second most important factor.

How do I maintain confidentiality during the sale?

Your M&A advisor presents the business to pre-qualified buyers under NDA. Residents, families, and staff are typically not informed until heads of terms are agreed, and sometimes not until completion. This protects occupancy levels and staff morale during the process.

What happens to staff when a care home is sold?

Staff transfer to the new owner under TUPE (Transfer of Undertakings - Protection of Employment) regulations. Their terms, conditions, and continuity of service are protected. The registered manager may continue in post or be replaced, subject to CQC approval.

Can I sell a care home with a mortgage or charge?

Yes, but the mortgage or charge must be settled at or before completion. Your solicitor will arrange for discharge from the lender, typically funded from the sale proceeds. Outstanding loans reduce the net proceeds you receive.

When should I start preparing to sell?

At least 12 months before you plan to market. This gives time to address any CQC issues, improve financial performance, reduce owner dependency, and organise records. Sellers who prepare thoroughly achieve higher multiples and faster completions.

Take the Next Step

If you own a UK care home and are considering your options, the data is clear - buyer demand is at record levels, multiples are strong, and the supply-demand imbalance in UK care beds means well-run homes are prized assets.

Whether you own a single 20-bed residential home or a portfolio of nursing care facilities, contact the DealFlowAgent advisory team for a confidential conversation about your business and what a sale could look like in the current market.

Your Advisory Team

Experienced Dealmakers Lead Your Exit

Every exit is led by a senior advisor who has been through it themselves. Meet the team who will guide you.

Joe Lewin

Founder & Lead Advisor

• •Built and sold first company after scaling to 80,000 users in 18 months
• •Raised £2m+ funding, built 12,000+ buyer network
• •Worked on 20+ transactions, spoken to hundreds of acquirers
• •Full-stack developer, building AI agents and SaaS platforms

Joe Thomason

Senior M&A Advisor

• •Previously Analyst at KBS Corporate
• •Analyst at Hampleton Partners, Associate at Tech Credit Partners
• •Worked on 25+ completed transactions (£300k to £120m)
• •Specialist in debt lending for business buyers

Emerson Patton

Sector Specialist: Building, Construction & Trade Services

• •20+ years advising owners in building services, fire safety, HVAC, plumbing, and construction
• •Guided 200+ companies through growth, profit improvement, and exit planning
• •Builds equity value and operational structure long before a sale
• •Partners with DFA to prepare owners for exit while the advisory team runs the sale

Sam Pouyan

Senior M&A Advisor

• •10 years across buy-side and sell-side M&A
• •Former investment banking analyst
• •Expert in financial modelling and deal structuring

Sage

AI Deal Concierge

• •Available 24/7. Monitors every signal in your deal
• •Keeps your advisory team one step ahead at all times
• •Trained on thousands of M&A transactions

Tim Armoo

Partner & Chief Marketing Officer

• •Founded Fanbytes, scaled revenues to £10m+, exited at multi-eight-figure valuation
• •Advises on multiple M&A deals, invests in early-stage ventures
• •Built 700,000+ follower community teaching founders to scale and sell
• •Partnered with DealFlowAgent to expand access for founders to buyers

Assigned Per Deal

Sector Expert

Industry-Specific M&A Advisor

For every deal, our advisory team includes a sector specialist from that client's specific industry and niche: bringing relationships, insider knowledge, and leverage to support your process and achieve the best acquisition outcome.

Healthcare M&A Specialists

Thinking of selling your healthcare business?

DealFlowAgent is the UK and US's only M&A advisory firm specialising in healthcare businesses. Our trusted advisors leverage industry knowledge, buyer relationships and proprietary technology to help business owners secure multiple acquisition offers at higher valuations.

Talk to a Real Advisor - No Obligation

Speak with Joe or Sam about your situation. No hard sell, no commitment, just honest advice from advisors who've been through it.

What's Your Business Actually Worth?

Our valuation tool gives you a realistic range based on recent comparable transactions in your sector. Takes 3 minutes.

Related Articles